Download 67th SCIENTIFIC SESSIONS CORPORATE SUPPORTED

77th SCIENTIFIC SESSIONS CORPORATE SYMPOSIA AT-A-GLANCE
FRIDAY, JUNE 9, 2017:
6:30 p.m. – 9:10 p.m.
CVOTs and Combination Therapy: Updates and Advances at ADA 2017
Sponsored by Medscape
Supported by an educational grant from AstraZeneca
(6:30 p.m. – 7:00 p.m. - Registration and Dinner Buffet/7:00 p.m. – 9:10 p.m. – Program)
In this symposium, leading experts will discuss the latest cardiovascular (CV) outcomes trial data for
newer type 2 diabetes (T2D) agents and the role of oral combination therapies.
Location: Marriott Marquis San Diego Marina, Marriott Grand Ballroom 1-6
Contact: Robert Zorzi / Phone: 514-944-9766
6:30 p.m. - 9:15 p.m.
Optimizing Comprehensive Glycemic Management in Challenging Patients with Type 2 Diabetes
Sponsored by CMEducation Resources
Supported by an educational grant from Sanofi Diabetes
This CME symposium will focus on the role, indications, guidelines, and evidence supporting optimal
approaches to early and guideline‐directed use of basal insulin therapy for diabetes—and subsequently,
its use in new combinations with GLP‐1 receptor agonists to optimize pan‐glycemic (FPG and PPG)
control to achieve desired ADA HbA1c target goals.
Location: Marriott Marquis San Diego Marina, Marriott Grand Ballroom 8-13
Contact: Milo Falcon / Phone: 678-662-1132
6:30 p.m. - 9:30 p.m.
La Evolución Continua en el Tratamiento de la Diabetes tipo 2 : Alcanzando los Objetivos con Mayor
Seguridad (presentado en Español)
Patrocinado conjuntamente por La Universidad de Texas Southwestern Medical Center y Worldwide
Initiative for Diabetes Education
Realizado a través del patrocinio educativo sin restricciones otorgado por Novo Nordisk A/S
(6:30 p.m. – 6:45 p.m. - Registration and Dinner/6:45 p.m. – 9:30 p.m. – Educational Program)
La Diabetes Tipo 2 es una enfermedad progresiva que presenta oportunidades únicas para el uso seguro,
oportuno y adecuado de la insulina. Nuestro simposio realiza un enfoque más profundo para lograr un
control glicémico óptimo e individualizado de los pacientes mediante la exploración de: una nueva
esperanza en los ensayos de resultados cardiovasculares, nuevas recomendaciones para hiperglicemia
de la ADA/EASD, métodos de intensificación temprana de insulina, y la combinación de insulina basal y
agonistas de GLP-1.
Updated 5/18/17
Location: Hilton San Diego Bayfront, Sapphire Ballroom A-N
Contacts: Jane Savio / E-mail: [email protected] / Phone: 212-614-4337
Mark Vinciguerra / E-mail: [email protected] / Phone: 214-648-4852
SATURDAY, JUNE 10, 2017:
5:30 a.m.- 7:45 a.m.
Continuous Glucose Monitoring as Standard of Care: Clinical Outcomes, Improved Access and
Therapeutic Use
Sponsored by CogniMed Inc.
Supported by an educational grant from DexCom
Published RCTs/outcomes studies (DlaMonD (MDI+ CGM for T1/T2 patients), GOLD Study,
REPLACE BG) will be applied to clinical practice and CGM-based treatment decisions. The new
designation of CGM with CMS for increased access to the senior population will be explored.
Illustrative cases utilizing Real-Time CGM will be presented.
Location: Hilton San Diego Bayfront, Sapphire Ballroom A-N
Contact: Jeffrey Rosenberg / E-mail: [email protected]
6:15 p.m. - 9:15 p.m.
Novel Approaches to Improving Adherence in T2D
Sponsored by Medscape Education
Supported by an educational grant from Intarcia Therapeutics, Inc.
(6:15 p.m. – 6:45 p.m. - Registration and Dinner Buffet/6:45 p.m. – 9:15 p.m. – Program)
In this symposium, leading experts in diabetes will discuss novel strategies to address medication
nonadherence in patients with type two diabetes (T2D).
Location: Marriott Marquis San Diego Marina, Marriott Grand Ballroom 1-6
Contact: Robert Zorzi / Phone: 514-944-9766
6:15 p.m. - 9:15 p.m.
The Physiologic and Mechanistic Rationale for Achieving HbA1c Target Goals with BASAL INSULIN in
VULNERABLE PATIENTS with Type 2 DIABETES
Sponsored by CMEducation Resources
Supported by an educational grant from Sanofi Diabetes
This CME activity will focus on the evidence supporting optimal approaches to early use and
intensification of basal insulin therapy for diabetes, and when appropriate and indicated, consideration
of and conversion to more “physiologic” formulations of long‐acting, basal insulin with potentially
advanced safety and/or efficacy profiles.
Location: Marriott Marquis San Diego Marina, Marriott Grand Ballroom 8-13
Contact: Milo Falcon / Phone: 678-662-1132
Updated 5/18/17
6:15 p.m. - 9:15 p.m.
The Clinical Benefits of Flash Continuous Glucose Monitoring
Sponsored by Abbott Diabetes Care
Supported by an educational grant from Abbott Diabetes Care
•
•
•
•
The benefits of Flash CGM in T1DM
Sub-analysis from the IMPACT RCT
The SELFY study in the pediatric population using Flash CGM
Clinical benefits with Flash CGM in the Real World
Location: Hilton San Diego Bayfront, Sapphire Ballroom A-N
Contact: Kappi Bowen / Phone: 510-749-6392
SUNDAY, JUNE 11, 2017:
6:15 a.m.- 7:45 a.m.
DCRI Evidence to Practice Series: Management of Diabetes for Heart Failure Patients
Sponsored by Duke Clinical Research Institute
Supported by an educational grant from Boehringer Ingelheim
(6:15 a.m. – 6:45 a.m. - Breakfast/6:45 a.m. – 7:45 a.m. – Program)
Over the last several years a new body of research has emerged around the prevalence and treatment
options for patients with type 2 diabetes and heart disease. Significantly, diabetes has been shown to
be a major risk factor for heart failure. New results from cardiovascular outcome trials and observational
studies will be discussed through case based learning led by multi-disciplinary experts. CME will be
jointly provided by the Duke University Health System Department of Clinical Education and Professional
Development and Duke Clinical Research Institute.
Location: Hilton San Diego Bayfront, Sapphire Ballroom C-P
Contact: Cara Abram / Phone: 919-668-3965
6:45 p.m. - 9:15 p.m.
Supporting your Patient's Climb to Success: Stepwise Progression for Using Obesity Pharmacotherapy
for Weight Management in Patients with Type 2 Diabetes
Sponsored by The Institute for Medical & Nursing Education, Inc.
Supported by an educational grant from Novo Nordisk Inc.
(6:45 p.m. – 7:15 p.m. - Registration and Dinner/7:15 p.m. – 9:15 p.m. – Educational Program)
This symposium will focus on current treatment recommendations for the comprehensive treatment of
obesity in adults with type 2 diabetes. Current presentations and interative case discussions will allow
faculty to provide feedback relative to decision processes that may be encountered in the context of
obesity management. Participants will use a decision tool worksheet, which can be applied in everyday
practice, to choose a treatment approach for each case.
Updated 5/18/17
Location: Hilton San Diego Bayfront, Sapphire Ballroom C-P
Contact: Amy Carbonara / Phone: 404-443-1513
6:45 p.m. - 9:30 p.m.
Individualized T2D Plans in the midst of CVOTs Galore: Applying the Data in a Practical Sense
Sponsored by Medscape
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly USA,
LLC
(6:45 p.m. – 7:15 p.m. - Registration and Dinner Buffet/7:15 p.m. – 9:30 p.m. – Program)
In this symposium, leading experts in diabetes will discuss clinical application of recent CVOT data using
realistic case scenarios.
Location: Marriott Marquis San Diego Marina, Marriott Grand Ballroom 1-6
Contact: Robert Zorzi / Phone: 514-944-9766
MONDAY, JUNE 12, 2017:
6:45 p.m. – 9:15 p.m.
Understanding and Managing a Complex Dual Dilemma: Diabetes and Dyslipidemia
Provided by Vindico Medical Education
Supported by an educational grant from Amgen
This CME activity will review current evidence about the pathophysiological consequences of
dyslipidemia in patients with diabetes as well as the impact of non-LDL-C lipids on cardiovascular risk.
The use of non-statin agents for patients who have not achieved their LDL-C goals will also be evaluated.
Location: Marriott Marquis San Diego Marina, Marriott Grand Ballroom 1-6
Contacts: Emily Scully / Phone: 856-994-9400 x376
Updated 5/18/17